Skip to main content
Clinical Trials/NCT04615689
NCT04615689
Withdrawn
Not Applicable

The Association of Gut Microbiota With Urinary Tract Infection in Infants

Hallym University Kangnam Sacred Heart Hospital1 site in 1 countryDecember 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Urinary Tract Infections
Sponsor
Hallym University Kangnam Sacred Heart Hospital
Locations
1
Primary Endpoint
The differential compositional analysis of the gut microbiota between healthy controls and infants with febrile urinary tract infection.
Status
Withdrawn
Last Updated
4 years ago

Overview

Brief Summary

This prospective case-control study will compare the gut microbiota between the infants with febrile urinary tract infection and healthy infants.

Detailed Description

The investigators hypothesize that the gut environment reflected by intestinal microbiota influences the risk of urinary tract infection. This prospective case-control study will compare the gut microbiota between the infants with febrile urinary tract infection and healthy infants. The investigators will sequence the V3-V4 of the bacterial 16SrRNA genes from the feces and analyze the sequencing data by QIIME2.

Registry
clinicaltrials.gov
Start Date
December 1, 2021
End Date
December 1, 2023
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Hallym University Kangnam Sacred Heart Hospital
Responsible Party
Principal Investigator
Principal Investigator

Ky Young Cho

Associate Professor

Hallym University Kangnam Sacred Heart Hospital

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of febrile urinary tract infection.

Exclusion Criteria

  • Congenital kidney disease
  • Congenital heart disease
  • Other metabolic disease

Outcomes

Primary Outcomes

The differential compositional analysis of the gut microbiota between healthy controls and infants with febrile urinary tract infection.

Time Frame: An average of 1 year, after the completion of recruitment.

The investigators will sequence the V3-V4 of the bacterial 16SrRNA genes from the feces and analyze the sequencing data by QIIME2. From the OTU table, the investigators will conduct the differential compositional analysis of the gut microbiota between healthy controls and infants with febrile urinary tract infection, using the linear discriminant analysis and analysis of differential abundance taking sample variation into account in R program and QIIME2.

Secondary Outcomes

  • The differential functional analysis of the gut microbiota between healthy controls and infants with febrile urinary tract infection.(An average of 1 year, after the completion of recruitment.)

Study Sites (1)

Loading locations...

Similar Trials